Navigation Links
Nephros Reports 2010 First Quarter Financial Results
Date:5/13/2010

Nephros' net loss was approximately $528,000 or $0.01 per basic and diluted common share for the first quarter of 2010 versus a net loss of approximately $735,000 or $0.02 per basic and diluted common share in the fourth quarter of 2009. Nephros' net loss decreased $207,000 or 28% in the current quarter primarily due to the approximately $213,000 or 29% reduction in loss from operations in the first quarter of 2010 compared to the same period in 2009.

End-Stage Renal Disease (ESRD) Products

Nephros completed the patient treatment phase of the U.S. clinical trial evaluation of the OLpur™ H2H™ module and OLpur™ MD 220 filter during the second quarter of 2008. The Company submitted the clinical data to the FDA with the 510(k) application for U.S. marketing approval of these products in November 2008.  Following its review of the application, the FDA requested additional information from us.  We replied to the FDA inquiries on March 13, 2009.  The FDA has not provided us with any additional requests for information or rendered a decision on our application.  We have made inquiries to the FDA about the status of our application and have most recently been informed that as of March 10, 2010 our application is still under their review process.  Nephros believes that, if approved, its technology would be the first FDA-approved on-line HDF therapy available in the U.S.

Water Ultrafiltration Products

On July 1, 2009, we received FDA approval to market the DSU to be used to filter bio
'/>"/>

SOURCE Nephros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nephros Signs Development Agreement with STERIS
2. Nephros Signs Canadian Distribution Agreement with Bellco Health Care Inc.
3. Nephros Reports 2009 Third Quarter Financial Results
4. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
5. DUSA Pharmaceuticals Reports Notice of Allowance for Key PDT Device Patent
6. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
7. ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohns Disease at the Digestive Disease Week (DDW) 2010 Conference
8. Fake Pharmacy Licenses, No-Prescription Meds OK with Internet Companies, LegitScript Reports
9. Stimatix GI Reports Encouraging Interim Results
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Repligen Reports Notice of Allowance of a United States Patent Covering the Use of Uridine to Treat the Symptoms of Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... -- Eli Lilly and Company (NYSE: LLY ) announced today ... for up to $1.6 billion aggregate principal amount of certain ... who tendered, and did not validly withdraw, their notes on ... time, on May 27, 2015 (the early tender date), ... to receive the total consideration. The total consideration for each ...
(Date:5/28/2015)... DUBLIN , May 28, 2015 /PRNewswire/ ... ) has announced the addition of Jain ... and Companies"  to their offering.  ... interference (RNAi) or gene silencing involves the ... inside the cell, this material is processed ...
(Date:5/28/2015)... May 28, 2015 AlloSource ®, ... cellular, bone, skin and soft-tissue allografts for use ... patient healing, today announced that AlloWrap® DS, its ... to the high-cost reimbursement category. ... and their patients," said Kimberly French , ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2
... WEBSTER, Texas, Nov. 10, 2011 IDEV Technologies, Incorporated ... for the company,s 6 French (6Fr) SUPERA VERITAS Transhepatic ... for sale outside the U.S. earlier this year, is ... the unique SUPERA stent, currently cleared in the U.S. ...
... Vascular Designs, Inc., a medical device manufacturing company, today ... FDA marketing clearance in 2009 – is now in ... in the treatment of liver cancer. The IsoFlow™ Infusion ... target and isolate areas within the body where the ...
Cached Medicine Technology:IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System 2Breakthrough Cancer Treatment Now in Use at UC Davis Medical Center 2
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... May 29, 2015 OncLive proudly announces ... dozen medical pioneers recognized by a panel of eminent ... of cancer treatment. Honorees will be introduced and celebrated ... Award Ceremony, held 8:30-11:00 p.m. CDT at The Chicago ... honorees are being recognized for groundbreaking accomplishments, in fields ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 Oaksterdam University, the ... June, this time to host its popular and highly demanded ... 14, and 15 from 10:00 am to 5:30 pm each day. ... Cannabis Job Fair will be held on June 14 from ... Fair will be held at the Plaza Hotel & Casino in ...
(Date:5/29/2015)... 29, 2015 Designed with the versatile ... to create an all new, exclusive line of supplementation ... with the latest and greatest, high impact, result driven ... be effective. The 24/7 Series can be used by ... even the casual fitness enthusiasts. There are no stimulant ...
(Date:5/29/2015)... MN (PRWEB) May 29, 2015 As ... Patio and Metro series outdoor saunas have increased in ... landscaping projects, and work at summer cottages. While ... piqued interest in summer projects a few weeks earlier ... suburban communities with smaller lot sizes tend to prefer ...
Breaking Medicine News(10 mins):Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:As Summer Approaches, Finnleo Notes Increased Interest in Patio and Metro Outdoor Saunas 2
... GMPs and adverse event reportingWASHINGTON, March 2 ... Accountability Office (GAO) of a report on the ... Products Association (NPA) released the following statement from ... Association appreciates having the opportunity to be included ...
... Commission wildlife biologists continue to monitor bat hibernacula, the ... or dying from White Nose Syndrome (WNS) has risen ... Carbondale, Lackawanna County; an abandoned mine near Shickshinny, Luzerne ... and Seawra Cave in Mifflin County."We continue to receive ...
... Increases 72% from Prior YearDUBLIN, Calif., March 2 ... company dedicated to the discovery and development of novel ... quarter and year ended December 31, 2008. The Company ... of $2.6 million, or $0.04 per share, compared with ...
... March 2 Align Technology, Inc. (Nasdaq: ... of Invisalign Teen(TM) for non-adult, comprehensive orthodontic treatment. ... and demonstrated effectiveness of the Invisalign(R) system, with ... of permanent teeth, and root-movement control - issues ...
... HOLLYWOOD, Calif., March 2 IPC The Hospitalist Company, Inc. (Nasdaq: ... today announced financial results for the fourth quarter and full year ... , Net revenue ... area net revenue growth of 19% , ...
... and T-shirts are likely to drink more or become binge ... All those T-shirts, hats and other items promoting alcoholic beverages ... fashion statement. , , Teens who own such merchandise are ... new study contends. , The Dartmouth scientists who did the ...
Cached Medicine News:Health News:Natural Products Association Comments on New GAO Report on Regulation of Dietary Supplements 2Health News:WNS Identified at Six Sites in Pennsylvania 2Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 2Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 3Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 4Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 5Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 6Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 7Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 8Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 9Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 10Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 11Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 12Health News:Align Technology Announces International Availability of Invisalign Teen(TM) 2Health News:Align Technology Announces International Availability of Invisalign Teen(TM) 3Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 2Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 3Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 4Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 5Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 6Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 7Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 8Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 9Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 10Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 11Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 12Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 2Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 3Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 4
Codman periosteal elevators, sharp, length 8" (203 mm), blade width 3/16" (5 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Cushing periosteal elevators, rounded edge, sharp, wide, blade width 5/8" (16 mm), length 7 1/4" (184 mm)....
Lederer periosteal elevators....
Medicine Products: